345 related articles for article (PubMed ID: 15963750)
21. The rights of blood recipients should supersede any asserted rights of blood donors.
Brooks JP
Vox Sang; 2004 Nov; 87(4):280-6. PubMed ID: 15585024
[TBL] [Abstract][Full Text] [Related]
22. [Viral safety concept: application to blood and blood products].
Trouvin JH
Rev Prat; 2005 Nov; 55(18):2033-8. PubMed ID: 16419908
[TBL] [Abstract][Full Text] [Related]
23. Blood pre-donation deferrals--a teaching hospital experience.
Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
[TBL] [Abstract][Full Text] [Related]
24. [Microbial safety of blood products].
Höher PG
Infusionsther Transfusionsmed; 1996 Feb; 23(1):42-58. PubMed ID: 8653017
[TBL] [Abstract][Full Text] [Related]
25. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of national regulations concerning blood safety across Europe.
Mascaretti L; James V; Barbara J; Cárdenas JM; Blagoevska M; Haracić M; Rossi U
Transfus Med; 2004 Apr; 14(2):105-12. PubMed ID: 15113375
[TBL] [Abstract][Full Text] [Related]
27. [Clinical selection of blood donors].
Danic B
Transfus Clin Biol; 2003 Jun; 10(3):227-33. PubMed ID: 12798862
[TBL] [Abstract][Full Text] [Related]
28. Guidelines for transfusion in Norway.
Hervig T; Flesland O; Svenningsen V; Bosnes V
Transfus Apher Sci; 2004 Dec; 31(3):181-4. PubMed ID: 15556464
[TBL] [Abstract][Full Text] [Related]
29. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
Polizzotto MN; Wood EM; Ingham H; Keller AJ;
Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
[TBL] [Abstract][Full Text] [Related]
30. [Blood transfusion practice].
Marchand J; Gouëzec H
Transfus Clin Biol; 2005 Jun; 12(2):180-5. PubMed ID: 15894498
[TBL] [Abstract][Full Text] [Related]
31. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
[TBL] [Abstract][Full Text] [Related]
32. Viral safety of human plasma-derived medicinal products: impact of regulation requirements.
Velthove KJ; Over J; Abbink K; Janssen MP
Transfus Med Rev; 2013 Jul; 27(3):179-83. PubMed ID: 23886505
[TBL] [Abstract][Full Text] [Related]
33. [Transfusion medicine in unified Europe].
Grigutsch V
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():12-5. PubMed ID: 7841774
[TBL] [Abstract][Full Text] [Related]
34. [Blood donation intended for the transfusion of anemic premature infants].
Velin P; Four R; Matta T; Dupont D
Pediatrie; 1993; 48(11):796-800. PubMed ID: 8058440
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
[TBL] [Abstract][Full Text] [Related]
36. Whole-blood donation: blood donor suitability and adverse events.
Newman BH
Curr Hematol Rep; 2004 Nov; 3(6):437-43. PubMed ID: 15496278
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
[TBL] [Abstract][Full Text] [Related]
38. Minimizing donor exposure in hemotherapy.
AuBuchon JP
Arch Pathol Lab Med; 1994 Apr; 118(4):380-91. PubMed ID: 8166588
[TBL] [Abstract][Full Text] [Related]
39. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
40. Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Final rule.
Centers for Medicare & Medicaid Services, HHS
Fed Regist; 2008 Jun; 73(125):36469-71. PubMed ID: 18677830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
